Published on:

Cutting Edge Clinical Trial Recruiting Mesothelioma Patients for Research and Treatment Offered at Four California Medical Centers

Mesothelioma patients are currently being recruited from all over the state of California to participate in a clinical trial studying the four month progression-free survival in patients with unresectable malignant pleural mesothelioma, after treatment with the drug Everolimus.
1156714_perscription_drug_case.jpg
Everolimus, also known by the brand name Afinitor, is a relatively new drug that has been used by cancer doctors since 2009 to treat advanced renal cell carcinoma (cancer of the kidney). Typically, the drug Everolimus has been prescribed in circumstances when other medications have proven to be unsuccessful in treating the cancer cells.

Similar to the conditions present in the mesothelioma clinical trial that is now occurring in California, Everolimus is also used to treat inoperable brain tumors that cannot be treated with surgery, in patients with a genetic condition that causes tumors to grow in many organs.

Everolimus treats cancer by inhibiting the reproduction of cancer cells and by decreasing their blood supply. It is the type of drug known as kinase inhibitor.

Patients who are accepted into the mesothelioma clinical trial will receive oral Everolimus once every day for 28 days. This course of medication will repeat every twenty eight days in the absence of disease progression or any evidence of unacceptable toxicity in the patients. After completion of the treatment, the patient’s health will be monitored and followed by the oncologists conducting the study for three years.

 

 

Attorney Mike Mandelbrot, founder of the Asbestos Legal Center in San Francisco, who has pledged hundreds of thousands of dollars to mesothelioma medical research, hailed the study. “In the fight against mesothelioma, cutting edge research is vital in the effort to defeat the disease.”

Mesothelioma is an incurable cancer caused by exposure to asbestos. Individuals, such as those whom served in the United States Navy, or whom were employed in the construction industry, later develop mesothelioma decades after their exposures to asbestos have occurred. There are thousands of new cases of mesothelioma diagnosed every year in the United States. Litigation resulting from asbestos caused disease, such as mesothelioma, has both curbed the use of asbestos domestically in the United States, and provided compensation to thousands of victims and their families. Often times that compensation is used for medical bills resulting from the disease, such as surgery, overnight hospital stays, and other medical treatments.

And in somes cases the costs of treatments provided in clinical trials are covered by the oncology treatment center conducting the research, by a grant from the government, or by the pharmaceutical company associated with the drug that is being researched.

Individuals with mesothelioma over the age of 18, of either sex, are encouraged to discuss whether or not to apply for acceptance into the clinical trial with their treating physicians.

The Callifornia locations where the Everolimus clinical trial is occurring include: Marysville, California; Orange, California; Pleasanton, California; and Davis, California. The Everolimus Mesothelioma clinical trial is also occurring at locations outside of the state of California.

If you or a loved one are suffering from mesothelioma, lung cancer, or any other asbestos related diseases, or would like more information relating to the information discussed above, you can call the Asbestos Legal Center for a free consultation, at 1-800-970-3878.